Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
Future Prospects | Analyst projections paint a promising picture with EPS estimates of $13.70 for 2025 and $15.08 for 2026, and price targets ranging from $118 to $188. |
Regulatory Resilience | Learn how Globe Life is rebounding from regulatory scrutiny, with diminished DOJ inquiry risks contributing to stock recovery and improved market sentiment. |
Growth Amid Headwinds | Explore Globe Life's strategic expansion of its agent force, driving organic growth and competitive edge in life insurance, while navigating health insurance margin pressures. |
Insurance Powerhouse | Globe Life Inc., a $9.9 billion market cap insurer, shows robust financial health with a 3.03 score, despite recent challenges in meeting analyst expectations. |
Metrics to compare | GL | Sector Sector - Average of metrics from a broad group of related Financials sector companies | Relationship RelationshipGLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 9.1x | 14.5x | 9.5x | |
PEG Ratio | 0.51 | 0.28 | 0.03 | |
Price / Book | 1.8x | 1.7x | 1.0x | |
Price / LTM Sales | 1.8x | 1.6x | 2.8x | |
Upside (Analyst Target) | 26.6% | 21.5% | 22.4% | |
Fair Value Upside | Unlock | 11.2% | 3.3% | Unlock |